OR
OR
CME on DPP4 Inhibitors Beyond Simple GLP-1 Effects
Dr AG Unnikrishnan is the CEO of Chellaram Diabetes Institute, a state-of-the-art diabetes hospital in Pune. He heads clinical care, research, education and also oversees a philanthropic rural diabete care program at the Institute.